Personal profile
His Neurosurgical training took place at major teaching institutions in Berlin, Krankenhaus Neukölln under Prof J Zierski and in Sheffield Royal Hallamshire Hospital under Mr D Forster, Mr J Jakubowski, Mr RDE Battersby and Mr AA Kemeny (February 1994 to June 1996). Here, Mr Radatz’s interest in gamma knife radiosurgery was established. After his return to Berlin, he completed his Neurosurgical training in May 1997, continuing as Facharzt under Prof J Zierski.
In October 1997, he moved to the Neurosurgical Unit in Oxford, UK to further his training, in particular in Functional Neurosurgery working with Prof Tipu Aziz and more complex Skull Base Surgery working with Mr C Adams and Mr R Kerr. He was appointed to his current position as Consultant Neurosurgeon in May 1999 in Sheffield. Mr Radatz has been Lead Clinician from 2002 for over 5 years and was appointed by the Yorkshire and Humber Deanery as Program Director for the Sheffield/Hull rotation. Additionally, he has been appointed to serve as Member of the SAC in Neurosurgery.
Mr Radatz has developed specialist expertise in spinal and complex spinal surgery (image-guided and assisted) as well as stereotactic radiosurgery. He is the Director and Lead Clinician of the National Centre for Gamma Knife Radiosurgery in Sheffield with an excess of 800 patients throughout the year. Mr Radatz’s treatment portfolio comprises more than 3,500 treatments including specialist expertise in treating even rare conditions utilising all models of the gamma knife and witnessing its evolution over more than the last decade.
As a core member, Mr Radtaz represents radiosurgery in the neuro-oncological and vascular multi-disciplinary team (MDT). He is IRMER-trained, with the most recent update taking place in 2015, and had extensive radiation protection training for diagnostic and treatment purposes including linac accelerator specifics. He has been fully trained in the use and utilisation of the gamma knife and cyber knife in the treatment for cranial and extra-cranial CNS lesions, including the treatment of spinal metastasis.
